Adial Pharmaceuticals, Inc.
ADIL
$6.45
-$0.20-3.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.71M | 4.58M | 5.88M | 4.61M | 5.92M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 133.00K | 218.80K | 299.70K | 407.50K | 163.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 28.85M | 4.80M | 6.18M | 5.01M | 6.08M |
|
|
|||||
| Total Current Assets | 28.85M | 4.80M | 6.18M | 5.01M | 6.08M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.00K | 2.60K | 2.80K | 2.90K | 3.10K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 29.09M | 5.23M | 6.67M | 5.66M | 6.80M |
|
|
|||||
| Total Accounts Payable | 2.62M | 573.60K | 655.20K | 556.30K | 671.10K |
| Total Accrued Expenses | 2.50M | 936.50K | 741.70K | 598.50K | 539.90K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.12M | 1.51M | 1.40M | 1.15M | 1.21M |
|
|
|||||
| Total Current Liabilities | 5.12M | 1.51M | 1.40M | 1.15M | 1.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 23.81M | -- | -- | -- | -- |
| Total Liabilities | 28.93M | 1.51M | 1.40M | 1.15M | 1.21M |
|
|
|||||
| Common Stock & APIC | 105.61M | 95.71M | 95.25M | 92.48M | 91.77M |
| Retained Earnings | -143.98M | -91.99M | -89.97M | -87.98M | -86.18M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -38.38M | 3.72M | 5.28M | 4.51M | 5.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 38.53M | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 38.53M | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.38M | 3.72M | 5.28M | 4.51M | 5.59M |
| Total Preferred Equity | 38.53M | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 156.00K | 3.72M | 5.28M | 4.51M | 5.59M |
|
|
|||||